Health Condition 1: N72- Inflammatory disease of cervix uteri Health Condition 2: K36- Other appendicitis
Conditions
Interventions
Intervention1: Intrathecal block: Duration of analgesia is assessed and duration of study is around 1 year
Control Intervention1: Dexmedetomidine 10 mcg and Nalbuphine 1 mg with Bupivacaine Heavy 0.5%
Sponsors
J L N Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Patients belonging to ASA grade 1 and 2 Informed consent undergoing infraumbilical surgery
Exclusion criteria
Exclusion criteria: Patientâ??s refusal Uncooperative patients Patient undergoing caesarean section Any known hypersensitivity or contraindication to Bupivacaine, Dexmedetomidine and Nalbuphine hydrochloride Local pathology at the site of injection or disability limiting the performance of spinal block History of convulsion, bleeding disorder, severe neurological deficit, thyroid disorder Patient with history of respiratory, cardiac, hepatic or renal disease (necessitating classification in ASA Class III or above) Patients having a history of significant neurological, psychiatric, or neuromuscular disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of analgesiaTimepoint: 1 year | — |
Secondary
| Measure | Time frame |
|---|---|
| Onset and two segment regression of sensory block. Onset and duration of motor block. Peri-operative sedation score Haemodyanamic changes. Adverse effect if any. Timepoint: 1 year | — |
Countries
India
Contacts
Public ContactDrArvind Khare
JLN Medical college, Ajmer
Outcome results
None listed